articleTop 1% cited
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
Psychopharmacology · 2006 · Vol. 187(3) · pp. 268–283
Roland R. Griffiths✉(Behavioral Pharma (United States))William A. Richards(Johns Hopkins University)U. McCann(Johns Hopkins University)Robert L. Jesse
Psychedelics and Drug StudiesCannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorPsilocybinPsychologyAnxietyHallucinogenClinical psychologyPerceptionPsychiatry
MeSH terms
AdultAffectBlood PressureDouble-Blind MethodFemaleHallucinogensHeart RateHumansLysergic Acid DiethylamideMalePsilocybinSurveys and QuestionnairesCross-Over StudiesSubstance-Related DisordersSpirituality
Funding
- National Institute on Drug Abuse
Citations
1,644
FWCI
24.33
field-weighted impact
References
55
Percentile
100%
vs. same field & year
Citations per year
Cited by
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
The Journal of Nervous and Mental Disease · 2014 · 732 citations
Predicting Responses to Psychedelics: A Prospective Study
Frontiers in Pharmacology · 2018 · 411 citations
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Frontiers in Pharmacology · 2018 · 794 citations
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Psychopharmacology · 2011 · 918 citations
Psychedelics Promote Structural and Functional Neural Plasticity
Cell Reports · 2018 · 1,094 citations
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
Neuropharmacology · 2011 · 408 citations
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Neuropsychopharmacology · 2017 · 647 citations
References
Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man
Clinical Pharmacology & Therapeutics · 1971 · 958 citations
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Neuroreport · 1998 · 1,009 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.